BMRN
+1.21 (+2.11%)
Biomarin Pharmaceutical Inc
Sector:
LIFE SCIENCES
PE Ratio (TTM):
21.67
Forward PE:
13.74
81
Overall Score
$58.66
$52.93
$94.85
Analyst Target
$95.91
▲
63.5%
76
Analyst Sentiment
69
Short-Term Risk
80
Long-Term Risk
80
Valuation
80
FCF Score
85
Revenue Growth
44
Inventory Mgmt
100
Profitability
88
Quality & Stability
38
Momentum
50
S&P500 Status